Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Multiple Myeloma
2:47
KarMMa-3 results: ide-cel vs standard regimens in triple-class exposed multiple myeloma
Sergio Giralt
• 17 Feb 2023
1:05
Novel CAR-T constructs emerging for patients with multiple myeloma who experience loss of BCMA
Hermann Einsele
• 10 Feb 2023
2:17
The importance of managing hematologic toxicity associated with CAR-T therapy
Marion Subklewe
• 10 Feb 2023
2:45
Phase I study of CC-98633 in R/R multiple myeloma
Luciano Costa
• 11 Dec 2022
5:56
Targeting neoantigens in multiple myeloma with CAR T-cell
Angela Krackhard
• 6 Apr 2022
1:27
Updates in cell and gene therapy approvals
Bruce Levine
• 27 Jan 2022
2:49
Exciting advances in CAR-T and TCR research
David Gilham
• 22 Feb 2021
6:10
Challenges of CAR T-cell therapy for AML: is CD38 the answer?
Lei Yu
• 3 Jun 2021
1:33
Improving education in cell therapy
Emanuele Ostuni
• 12 Apr 2021
1:27
The European cell & gene therapy landscape
Paige Bischoff
• 17 Mar 2021
2:21
A non-gene edited approach to allogeneic CAR-T development
Filippo Petti
• 6 Apr 2021
8:28
Investigating allogeneic iNKT cell therapy
Marc van Dijk
• 23 Feb 2021
4:15
CT053, anti-GPC3 CAR-T and targeting solid tumors
Hong Ma
• 19 Feb 2021
2:49
Myeloma Patients Europe: collaborating on projects to benefit the myeloma community
Ananda Plate
• 11 Feb 2021
1:52
CAR T-cells in myeloma: patients’ perspective
Ananda Plate
• 11 Feb 2021
3:48
The importance of partnering with patient organizations
Ananda Plate
• 11 Feb 2021
1
2
Next